Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

My little theory is that the concept of “imprinting” in psychology can just as easily be applied to programming: Much as a baby goose decides that the first moving life-form it encounters is its ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

The Frankfurt Book Fair opens its 77th edition with a robust lineup of professional programming for today—Wednesday, October 15. From CEO conversations to diversity panels, children’s publishing ...

What if you could strip away the layers of abstraction that operating systems impose and interact directly with your computer’s hardware? Imagine crafting a program where every instruction is executed ...

The finalists for this year's National Book Awards have been announced. Among the 25 nominees are novelists Rabih Alameddine and Megha Majumdar as well as journalists Julia Ioffe and Omar El Akkad, ...

This is an edition of the Books Briefing, our editors’ weekly guide to the best in books. Anna Holmes has never forgotten reading Judy Blume’s Forever as a tween. Why? Because the book, published 50 ...